Real-time enrollment status for this t-cell acute lymphoblastic lymphoma clinical trial
Current Status
Recruiting
Checked: September 7, 2026 at 6:13 AM UTC
| NCT Number | NCT03081910 |
| Recruiting Status | Recruiting |
| Condition | T-cell Acute Lymphoblastic Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 54 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Baylor College of Medicine |
| Last Updated on CT.gov | August 11, 2026 (3 weeks ago) |
As of September 7, 2026: Clinical trial NCT03081910 is currently recruiting participants. This phase1 study for t-cell acute lymphoblastic lymphoma is actively seeking new participants at 2 locations across the United States. The study is sponsored by Baylor College of Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03081910 is actively recruiting participants as of September 7, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03081910 was last updated 3 weeks ago (August 11, 2026). HelloStudys verifies this status automatically.